Technoclone is a world-leading producer of
diagnostics tests, equipment's and research products in the area of blood
clotting. The Technoclone it has the main focus was on monoclonal
antibodies against components of the coagulation and the fibrinolytic systems. Technoclone
was the first company offering a complete set of ELISAs and of a novel patented
system allowing determination of activity and antigen in the same sample
(Actibind) in the field of fibrinolysis.
Additionally, Technoclone has
new innovation vision where it has obligated to help overcome new complexity in
the diagnostics of hematological and cardio-vascular disorders. The focus of Technoclone´s
research and development are in the field of thrombosis and cardiovascular
diseases, which it is the main causes for mortality and morbidity. The research
and development are pursued in Technoclone´s own research division and
in close cooperation with Universities and international and national research
consortia.
Finally, Technoclone holds at
present more than 10 international patents in the field of diagnosis and
therapy of vascular diseases.
"30 YEARS COAGULATION ON OUR MIND "
(on the forefront of diagnostic challenges of tomorrow).
Certificates: EN ISO 9001, EN ISO 13485 , MDC
Certificate and MDSAP16 certificate 2016.